Holen Sie sich die Stockscreener-App
22.41
7.05%
-1.70
Handel nachbörslich:
22.41
Schlusskurs vom Vortag:
$24.11
Offen:
$24.16
24-Stunden-Volumen:
254.98K
Relative Volume:
0.73
Marktkapitalisierung:
$165.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-112.46M
KGV:
-13.66
EPS:
-1.64
Netto-Cashflow:
$-99.89M
1W Leistung:
-20.33%
1M Leistung:
-40.18%
6M Leistung:
+69.41%
1J Leistung:
+39.23%
1-Tages-Spanne:
$22.31
$24.50
1-Wochen-Bereich:
$22.31
$28.66
52-Wochen-Spanne:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Vergleichen Sie VOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
22.41 | 165.25M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-15 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Eingeleitet | Wedbush | Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Sell |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
How institutional ownership impacts Vor Biopharma Inc. stock2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Vor Biopharma Inc. stock retracement – recovery analysisWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Why Vor Biopharma Inc. stock could benefit from AI revolution2025 Short Interest & Fast Moving Trade Plans - newser.com
Will Vor Biopharma Inc. stock gain from government policiesEarnings Overview Report & Daily Stock Trend Reports - newser.com
Vor Biopharma Appoints New Chief Medical Officer - TipRanks
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - GlobeNewswire
Can a trend reversal in Vor Biopharma Inc. lead to recoveryMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Can Vor Biopharma Inc. stock beat analyst upgradesPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
Technical signs of recovery in Vor Biopharma Inc.Weekly Trade Summary & Daily Volume Surge Signals - newser.com
Risk adjusted return profile for Vor Biopharma Inc. analyzedJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Forecasting Vor Biopharma Inc. price range with options dataMarket Trend Review & Risk Managed Investment Strategies - newser.com
Long term hold vs stop loss in Vor Biopharma Inc.Market Volume Summary & Real-Time Buy Zone Alerts - newser.com
Vor Biopharma Inc. stock volume spike explainedVolume Spike & Community Trade Idea Sharing - newser.com
Applying big data sentiment scoring on Vor Biopharma Inc.Day Trade & Weekly Market Pulse Updates - newser.com
Vor Biopharma Inc. stock chart pattern explainedJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com
Using data models to predict Vor Biopharma Inc. stock movementWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Pattern recognition hints at Vor Biopharma Inc. upsideQuarterly Portfolio Report & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-02 01:05:22 - newser.com
Q3 EPS Estimates for Vor Biopharma Boosted by HC Wainwright - MarketBeat
Combining price and volume data for Vor Biopharma Inc.Weekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsCPI Data & Daily Profit Maximizing Tips - newser.com
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 124,311 Shares - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 251,518 Shares - MarketBeat
RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Vor Biopharma Inc. - GuruFocus
Vor Bio (NASDAQ: VOR) issues inducement equity to 20 new hires at $30.22 per share - Stock Titan
FY2028 EPS Estimates for Vor Biopharma Decreased by Analyst - MarketBeat
Published on: 2025-10-31 05:21:03 - newser.com
Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million By Investing.com - Investing.com Nigeria
Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million - Investing.com
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):